OmniActive says it’s ‘well positioned’ to take advantage of growing US interest in herbs and botanicals
By Mary Ellen Shoup
Last updated on
Since its acquisition of natural extract supplier Indfrag for $35 million last year, OmniActive Health Technologies is solidifying its presence in the US specialty botanicals and extracts market with a focus on healthy aging and healthy living.
Actual adverse events attributed to supplement-drug interactions are rare. Nevertheless, inquiries about the risks are on the rise, according to the American Botanical Council.
Sabinsa Corporation has prevailed in a patent infringement lawsuit against an Indian competitor based on the intellectual property supporting its Curcumin C3 Reduct technology.
As April draws to a close, definitive outcomes from the European Commission’s (EC) Regulatory Fitness and Performance (REFIT) programme, said to appear sometime in 2018, are still nowhere to be seen.